Composition containing natural killer T cells, useful e.g. for treating infection or cancer, activated by a phosphatidylinositol mannoside to induce a granulomatous response

摘要

A pharmaceutical composition (A) comprises natural killer T cells (NKT) activated by a phosphatidylinositol mannoside (PIM), and a carrier. An Independent claim is also included for activating NKT ex vivo by treating a sample containing them with PIM.